Sontuzumab (AS1402) is a humanized monoclonal antibody targeting MUC1 that binds to the extracellular MUC1 peptide sequence PDTR (Kd~1 nM) and can be used for breast cancer research.
Purity:
95.00%
CAS Number:
[372075-37-1]
Target:
Mucin
* VAT and and shipping costs not included. Errors and price changes excepted